Authors: WILSON DB BECK TM GUNDLACH CA

Citation: Db. Wilson et al., PACLITAXEL FORMULATION AS A CAUSE OF ETHANOL INTOXICATION, The Annals of pharmacotherapy, 31(7-8), 1997, pp. 873-875

Authors: BECK TM YORK M CHANG A NAVARI R HARVEY WH MESHAD M GRIFFIN D WENTZ A

Citation: Tm. Beck et al., ORAL ONDANSETRON-8-MG TWICE-DAILY IS AS EFFECTIVE AS 8-MG 3 TIMES DAILY IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MODERATELYEMETOGENIC CANCER-CHEMOTHERAPY, Cancer investigation, 15(4), 1997, pp. 297-303

Authors: PIRO L WHITE CA LOPEZ AJG JANAKIRAMAN N BECK TM SELANDER K DOWDEN S CZUCZMAN M LYNCH JW KOLITZ JE JAIN V

Citation: L. Piro et al., RITUXAN(TM) (RITUXIMAB, IDEC-C2B8) - INTERIM ANALYSIS OF A PHASE-II STUDY OF ONCE WEEKLY TIMES 8 DOSING IN PATIENTS WITH RELAPSED LOW-GRADEOR FOLLICULAR NON-HODGKINS-LYMPHOMA, Blood, 90(10), 1997, pp. 2272-2272

Authors: BECK TM

Citation: Tm. Beck, THE PATTERN OF EMESIS FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE AND THE ANTIEMETIC EFFICACY OF ONDANSETRON, Anti-cancer drugs, 6(2), 1995, pp. 237-242

Authors: NAVARI RM MADAJEWICZ S ANDERSON N TCHEKMEDYIAN NS WHALEY W GAREWAL H BECK TM CHANG AY GREENBERG B CALDWELL KC HUFFMAN DH GOULD JR CARRON G OSSI M ANDERSON EM

Citation: Rm. Navari et al., ORAL ONDANSETRON FOR THE CONTROL OF CISPLATIN-INDUCED DELAYED EMESIS - A LARGE, MULTICENTER, DOUBLE-BLIND, RANDOMIZED COMPARATIVE TRIAL OF ONDANSETRON VERSUS PLACEBO, Journal of clinical oncology, 13(9), 1995, pp. 2408-2416

Authors: HESKETH PJ HARVEY WH HARKER WG BECK TM RYAN T BRICKER LJ KISH JA MURPHY WK HAINSWORTH JD HALEY B PLAGGE P FLACK NE

Citation: Pj. Hesketh et al., A RANDOMIZED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS ONDANSETRON ALONE AND IN COMBINATION WITH INTRAVENOUS DEXAMETHASONE IN THE PREVENTION OF HIGH-DOSE CISPLATIN-INDUCED EMESIS, Journal of clinical oncology, 12(3), 1994, pp. 596-600